Memento Medicines, Inc.
Biotechnology · BOSTON, MA
BiotechnologySEC Form D
Memento Medicines, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 16, 2026, reporting $38,000,159 raised toward a $93,000,383 offering.
Incorporated in Delaware and based in BOSTON, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Memento Medicines, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Naveen Manu DaryaniExecutive Officer · Director · Promoter
- William Daley BonificioExecutive Officer · Promoter
- Stephen Basil ThomasExecutive Officer · Promoter
- Zach ScheinerDirector
- Dmitrij HristodorovDirector
- Megan KrenchDirector
- Vishal KapoorDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$19.1MRaised
Rapalogix Health, Inc.
$150.0KRaised
Chickadee Biomedicines, Inc.
$500.0KRaised
Boston Interactome, Inc.
$3.8MRaised
DINYA DNA, Inc.
$6.5MRaised